STEVENAGE BIOSCIENCE CATALYST

Company number 07196230 · Active · Stevenage SG1 2FX

B
Firmoscan score 72/100

STEVENAGE BIOSCIENCE CATALYST is an active private limited company (company number 07196230) incorporated on 19 March 2010, registered in Stevenage. Its registered activity is other business support service activities n.e.c. (SIC 82990). Latest full accounts cover the period ending 31 March 2025, showing net assets of £4.30m and cash of £1.54m, with 17 employees on average. Turnover was £4.09m and profit for the year −£683k. Net assets fell 14% on the prior period (£4.99m).

By net assets it sits in the top quarter of 1,586 comparable companies in Hertfordshire (median £3,000, upper quartile £47k).

Key dates

Incorporated
19 March 2010
Next accounts due
31 December 2026 — in 74 days
Confirmation statement due
2 April 2027 — in 166 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 82990
Other business support service activities n.e.c.
Accounts type
Full
Size band
Small (Companies Act thresholds)

Financials — 2 periods on record, latest ending 31 March 2025

Net assets
Net assetsMar 2024: £4.99m; Mar 2025: £4.30m£4.99m£4.30mMar 2024Mar 2025
Cash at bank
Cash at bankMar 2024: £2.11m; Mar 2025: £1.54m£2.11m£1.54mMar 2024Mar 2025
Turnover
TurnoverMar 2024: £5.46m; Mar 2025: £4.09m£5.46m£4.09mMar 2024Mar 2025
Profit for the year
Profit for the yearMar 2024: £614k; Mar 2025: −£683k£614k−£683kMar 2024Mar 2025
Average employees
Average employeesMar 2024: 17; Mar 2025: 171717Mar 2024Mar 2025
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 March 2025£4.30m£1.54m—£3.40m£4.09m−£683k17
31 March 2024£4.99m£2.11m—£3.72m£5.46m£614k17
Current ratio
1.06
Net margin
-16.7%
Cash per employee
£91k

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Firmoscan score: 72/100 (grade B)

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.

Ownership and control

  • The Wellcome Trust Limited (corporate entity, United Kingdom) — holds 25–50% of voting rights · since 6 April 2016
  • Glaxosmithkline Research & Development Limited (corporate entity, United Kingdom) — holds 25–50% of voting rights · since 6 April 2016
  • (persons with significant control statement) — · since 19 March 2017 · ceased 20 March 2017

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

Similar companies in Hertfordshire

Same activity (other business support service activities n.e.c.), closest in incorporation date.

Reminders for STEVENAGE BIOSCIENCE CATALYST

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.